South America Leukapheresis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)
Market Introduction
The South America Leukapheresis market is analyzed based on three large countries: Brazil, Argentina, and rest of SAM. Brazil is contributing a major share in the growth of leukapheresis market. In Brazil, sickle cell is among the most common hereditary diseases. Every year, 700 to 1000 children in Brazil are known to be born with SCD. The disease’s most common type is sickle cell anemia (SCA), which occurs due to a single mutation in the β-globin gene. In Brazil, the occurrence of sickle cell anemia is varied, with a significantly higher incidence in states such as Maranhão with higher poverty indexes and more significant numbers among individuals of African descent. The country has also recorded a rise in the cases of leukemia among children during recent years. The cases of leukemia in Brazil have increased with time and at present, is the 9th most common cancer in the country. Its prevalence is found to be considerably high among males and causes from 41.7 to 57.5 cases per million inhabitants. Also, the proportion of leukemia cases among regions is highly variable in the country and has risen since the last report by published the Instituto Nacional do Câncer (INCA). The Northern part of Brazil was identified to have the second-highest number of leukemia cases. It also has the lowest municipal human development index (mHDI), hence leading the highest childhood mortality rate. Therefore, owing to the rise in cases of sickle cell anemia and leukemia, the country is expected to offer growth opportunities for the market during the forecast period.
South America have been witnessing a growing number of COVID-19 cases since its outbreak. The cases are increasing in Brazil, Argentina, and Colombia. The COVID-19 is expected to result in the region's worst recession, causing a 9.1% contraction in regional GDP in 2020. This is expected to increase the number of poor up by 45 million and the extremely poor number by 28 million. The COVID? 19 pandemic is a critical test for the already overburdened and underfunded public healthcare systems of South America. It suffers from severe inequalities. State-run hospitals and clinics are already overstressed by the treatment of vector?borne diseases and community?acquired infections and high rates of non?communicable diseases (NCDs). Moreover, in South America, the Gross Domestic Product (GDP) and central government healthcare expenditure are significantly lower than in developed countries. In 2018, as per the United Nations, Economic Commission for Latin America (CEPAL), 16 South American countries invested less than 4% of their GDP to healthcare. The consequences of a lack of investment in public healthcare systems are reflecting during the pandemic. The COVID?19 pandemic is exacerbating these inequalities by threatening the infrastructure and capacity of state?owned healthcare systems. Thus, the factors mentioned above are negatively impacting the growth of the market in the region.
Get more information on this report :
Market Overview and Dynamics
The leukapheresis market in South America is expected to grow from US$ 4.92 million in 2021 to US$ 7.89 million by 2028; it is estimated to grow at a CAGR of 7.0% from 2021 to 2028. Blood diseases disturb the overall well-being of patients. Anemia; hemophilia; von Willebrand disease (VWD); blood cancers such as myeloma, leukemia, and lymphoma are among the common blood diseases. The number of newly diagnosed leukemia cases increased from 354,500 in 1990 to 518,500 in 2017. According to the Centers of Disease Control and Prevention (CDC), hemophilia A affects ~1 in 5,000 male births. The CDC survey for 2017 reported that Von Willebrand disease (VWD), one of the most commonly occurring bleeding disorders, affects up to 1% of the population. More than 14,600 men, women, and children were seen at hemophilia treatment centers for the treatment of VWD during 2012–2016. The rising incidence of these diseases maximizes the need for blood transfusion, thereby bolstering the demand for leukapheresis equipment. Two of the most common types of apheresis used for the removal of harmful substances from blood are cytapheresis and plasma exchange. Plasma exchange is used to treat disorders such as myasthenia gravis, thrombotic thrombocytopenic purpura, and multiple sclerosis. Cytapheresis, a process that removes the excess number of blood cells, is used in the treatment of leukemia, polycythemia, and thrombocythemia, among others.
Key Market Segments
In terms of product type, the leukapheresis disposables segment held a larger share in 2021. Based on application, research applications segment held the largest share in 2021. Based on end user, blood component providers and blood centers segment held the largest share in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the leukapheresis market in South America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Asahi Kasei Corporation; Fresenius SE & Co. KGaA; Haemonetics Corporation; Terumo Corporation; STEMCELL Technologies Inc.; HemaCare; Macopharma; AllCells; and BioIVT among others.
Reasons to buy report
- To understand the South America leukapheresis market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for South America leukapheresis market
- Efficiently plan M&A and partnership deals in South America leukapheresis market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form South America leukapheresis market
- Obtain market revenue forecast for market by various segments from 2021-2028 in South America region.
South America Leukapheresis Market Segmentation
South America Leukapheresis Market – By Product Type
- Leukapheresis Disposables
- Leukapheresis Devices
South America Leukapheresis Market – By Application
- Research Applications
- Therapeutic Applications
South America Leukapheresis Market – By End User
- Blood Component Providers and Blood Centers
- Hospitals and Transfusion Centers
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
South America Leukapheresis Market – By Country
- Brazil
- Argentina
- Rest of South America
South America Leukapheresis Market – Companies Mentioned
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South America Leukapheresis Market – By Product Type
1.3.2 South America Leukapheresis Market – By Application
1.3.3 South America Leukapheresis Market – By End User
1.3.4 South America Leukapheresis Market – By Country
2. South America Leukapheresis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South America Leukapheresis – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
5. South America Leukapheresis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Fostering Number of Voluntary Blood Donors
5.1.2 Elevating Incidence of Hematologic Diseases
5.1.3 Raising Elderly Population
5.2 Key Market Restraints
5.2.1 Excessive Cost of Leukapheresis
5.3 Key Market Opportunities
5.3.1 Amplifying Opportunities in Emerging Economies
5.4 Future Trends
5.4.1 Growth in Therapeutic Apheresis
5.5 Impact Analysis
6. South America Leukapheresis – Market Analysis
6.1 South America Leukapheresis Market Revenue Forecast and Analysis
7. South America Leukapheresis Market Analysis – by Product Type
7.1 Overview
7.2 South America Leukapheresis Market Share by Product Type 2021 & 2028 (%)
7.3 Leukapheresis Devices
7.3.1 Overview
7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Apheresis Devices
7.3.2.1.1 Overview
7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Leukapheresis ColuMillions and Cell Separators
7.3.2.2.1 Overview
7.3.2.2.2 Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Leukoreduction Filters
7.3.2.3.1 Overview
7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)
7.4 Leukapheresis Disposables
7.4.1 Overview
7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)
8. South America Leukapheresis Market Analysis – by Application
8.1 Overview
8.2 South America Leukapheresis Market Share by Application 2021 & 2028 (%)
8.3 Research Applications
8.3.1 Overview
8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Million)
8.4 Therapeutic Applications
8.4.1 Overview
8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)
9. South America Leukapheresis Market Analysis – by End-User
9.1 Overview
9.2 South America Leukapheresis Market Share by End-User 2021 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)
9.4 Blood Component Providers and Blood Centers
9.4.1 Overview
9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)
9.6 Hospitals and Transfusion Centers
9.6.1 Overview
9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)
10. South America Leukapheresis Market – Country Analysis
10.1 Overview
10.1.1 South America: Leukapheresis Market, by Country, 2021 & 2028 (%)
10.1.1.1 Brazil: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 Brazil: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.2 Brazil: Leukapheresis Market, By Product Type, 2019–2028 (USD Million)
10.1.1.1.2.1 Brazil: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.1.3 Brazil: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.1.4 Brazil: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.1.2 Argentina: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.1 Argentina: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.2 Argentina: Leukapheresis Market, By Product Type, 2019–2028 (USD Million)
10.1.1.2.2.1 Argentina: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.2.3 Argentina: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.2.4 Argentina: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.1.3 Rest of South America: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 Rest of South America: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.2 Rest of South America: Leukapheresis Market, By Product Type, 2019–2028 (USD Million)
10.1.1.3.2.1 Rest of South America: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.3.3 Rest of South America: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.3.4 Rest of South America: Leukapheresis Market, by End User, 2019–2028 (USD Million)
11. South America Leukapheresis Market – Impact of COVID-19 Pandemic
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Leukapheresis Market – Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Asahi Kasei Corporation
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Fresenius SE & Co. KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Haemonetics Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Terumo Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 STEMCELL Technologies Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 HemaCare
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Macopharma
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AllCells
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 BioIVT
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Brazil: Leukapheresis Market, By Product Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Brazil Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina: Leukapheresis Market, By Product Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. Argentina Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of South America: Leukapheresis Market, By Product Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of South America Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of South America Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of South America Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments Done by Companies
Table 14. Inorganic Developments Done by Companies
Table 15. Glossary of Terms, Leukapheresis Market
LIST OF FIGURES
Figure 1. South America Leukapheresis Market Segmentation
Figure 2. South America Leukapheresis Market Segmentation, By country
Figure 3. Leukapheresis Market Overview
Figure 4. Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market
Figure 5. Brazil to Show Significant Growth During Forecast Period
Figure 6. South America Leukapheresis Market, Industry Landscape
Figure 7. South America PEST Analysis
Figure 8. South America Leukapheresis market impact analysis of driver and restraints
Figure 9. South America Leukapheresis Market – Revenue Forecast and Analysis to 2020-2028
Figure 10. South America Leukapheresis Market Share by Product Type 2021 & 2028 (%)
Figure 11. Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. South America Leukapheresis Market Share by Application 2021 & 2028 (%)
Figure 17. Research Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. South America Leukapheresis Market Share by End-User 2021 & 2028 (%)
Figure 20. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. South America: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)
Figure 25. South America: Leukapheresis Market, by Country, 2021 & 2028 (%)
Figure 26. Brazil: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Argentina: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of South America: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact Of COVID-19 Pandemic In South America Market
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- BioIVT
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South America leukapheresis market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South America leukapheresis market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South America market trends and outlook coupled with the factors driving the leukapheresis market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution